Volume | 716,109 |
|
|||||
News | - | ||||||
Day High | 200.10 | Low High |
|||||
Day Low | 195.21 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Labcorp Holdings Inc | LH | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
197.91 | 195.21 | 200.10 | 199.88 | 196.48 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
17,739 | 716,109 | US$ 198.52 | US$ 142,162,532 | - | 191.97 - 243.30 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 77,366 | US$ 199.88 | USD |
Labcorp Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
16.82B | 84.10M | - | 12.16B | 418M | 4.97 | 40.23 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Labcorp News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LH Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 197.83 | 200.10 | 192.38 | 196.53 | 541,961 | 2.05 | 1.04% |
1 Month | 213.52 | 214.14 | 191.97 | 197.90 | 712,547 | -13.64 | -6.39% |
3 Months | 211.29 | 218.67 | 191.97 | 203.52 | 734,358 | -11.41 | -5.40% |
6 Months | 222.42 | 234.09 | 191.97 | 212.62 | 746,038 | -22.54 | -10.13% |
1 Year | 230.12 | 243.30 | 191.97 | 211.88 | 764,171 | -30.24 | -13.14% |
3 Years | 257.93 | 317.17 | 191.97 | 240.26 | 728,678 | -58.05 | -22.51% |
5 Years | 168.50 | 317.17 | 98.02 | 218.88 | 737,854 | 31.38 | 18.62% |
Labcorp Description
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market. |